The FINANCIAL -- Bayer initiates a global “Bee Care Program” to further promote bee health.

The FINANCIAL -- Top-line results with VEGF Trap-Eye after one year of treatment in the Phase 3 GALILEO study in patients with macular edema due to central retinal vein occlusion confirm the primary endpoint results that were seen after 24 weeks from the two pivotal trials, GALILEO and COPERNICUS.

The FINANCIAL -- Polyurethane materials for lightweight yet rigid designs are the focal point of Bayer MaterialScience’s exhibit at Stand P 14 at the JEC composites fair from March 27 - 29 in Paris, France.

The FINANCIAL -- Getting a good night's sleep may depend on the comfort that comes from living with loved ones, more than the quiet that comes from living alone.